Browse All

Current Filters

CLEAR FILTER x

TITLE

Real-world-data on Ofatumumab as First-line Treatment in Early RMS (AIOLOS study)

Author:Nelles, Gereon   Pfeuffer, Steffen   Wagner, Carola   

Session Name:P7: Multiple Sclerosis: Disease-modifying Therapies: Real-world Evidence and Adverse Events 1  

Topic:Multiple Sclerosis  

Program Number:P7.013  

Author Institution:Neuromed-Campus, Cologne, Germany  University Hospital Giessen, Giessen, Germany  Novartis Pharma GmbH, Nuremberg, Germany  

Remote Digital Self-Testing of Cognitive Impairment: Results of the re.cogni.ze Study on Feasibility and Acceptance with the NeotivCare App

Author:Nelles, Gereon   Düzel, Emrah   Bartes, Claudia   Czesnik, Dirk   Duning, Thomas   Lüschow, Andreas   Reifschneider, Gerd   Schöttler, Michael   Schott, Björn Henrik   Griebe, Martin   

Session Name:P9: Aging, Dementia, and Behavioral Neurology: Non-AD Dementia Diagnostics  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P9.008  

Author Institution:Neurologische Praxis, Koln, Germany  Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Magdeburg, Magdeburg, Germany  Klinik für Psychiatrie und Psychotherapie, Universitätsmedizin Göttingen, Deutsche Zentrum für Neurodegenerative Erkrankungen (DZNE), Göttingen, Göttingen, Germany  Gemeinschaftspraxis für Neurologie, Göttingen, Göttingen, Germany  Klinikum Bremen-Ost, Bremen, Germany  MVZ Campus Benjamin Franklin, Charité-Universitätsmedizin Berlin, Berlin, Germany  NeuroCentrum Erbach, Erbach, Germany  Roche Pharma AG, Grenzach-Wyhlen, Grenzach, Germany  Neurologische Klinik, Medizinische Fakultät Mannheim, Universität Heidelberg, Mannheim, Germany  

Longer-term (up to 6 Years) Efficacy and Safety of Ofatumumab in People with Non-highly Active MS Early in the Disease Course

Author:Ziemssen, Tjalf   Schuh, Katrin   Hentschke, Christian   Nelles, Gereon   

Session Name:P11: Multiple Sclerosis: Clinical and Translational Research in MS 1  

Topic:Multiple Sclerosis  

Program Number:P11.003  

Author Institution:University Clinic Carl-Gustav Carus, Dresden, Germany  Novartis Pharma GmbH, Nuremberg, Germany  Neuromed-Campus, Cologne, Germany